natgillin/translations-raw huggingface dataset:
Multipacks containing 6 (3 packs of 2) 125 microgram pre-filled pens (grey labelled pens). 
Skupna pakiranja, ki vsebujejo po 6 (3 pakiranja po 2) 125-mikrogramskih napolnjenih injekcijskih peresnikov (peresniki s sivimi nalepkami).
There are no data on the effects of peginferferon beta-1a on human fertility. 
Ni podatkov o vplivu peginferferona beta-1a na plodnost pri ljudeh.
Syringe label 
Oznaka na brizgi
• Hold the Plegridy pre-filled syringe at a 90° angle to the injection site. 
Plegridy držite pod kotom 90° na mesto injiciranja.
• Let the injection site dry before injecting the dose. 
• Pred injiciranjem odmerka počakajte, da se koža posuši.
See section 4 for the symptoms of an allergic reaction. 
Glejte poglavje 4 za simptome alergijske reakcije; - če imate hudo depresijo ali razmišljate o samomoru.
The syringe inside the pen is a 1 mL pre-filled syringe made of glass (Type I) with a bromobutyl rubber stopper and thermoplastic and polypropylene rigid needle shield, containing 0.5 mL of solution. 
6.5 Vrsta ovojnine in vsebina 1-ml napolnjena injekcijska brizga iz stekla (tip I) z zamaškom iz bromobutilne gume in termoplastičnim in polipropilenskim togim pokrovom za iglo, ki vsebuje 0,5 ml raztopine.
Supplies needed for your Plegridy Pen injection: 
Pripomočki, ki jih potrebujete za injiciranje zdravila Plegridy v injekcijskem peresniku:
Do not rest the pen on the injection site until you are ready to inject. 
Opozorilo: Injekcijskega peresnika ne položite na mesto za injiciranje, dokler niste pripravljeni na injiciranje.
Each inner carton contains 2 pens in a protective plastic tray. 
2 injekcijska peresnika na zatesnjenem plastičnem pladnju.
For example, if you are prescribed other medicines, or if you have a blood test. Plegridy may affect the other medicines or the test result. 
Zdravilo Plegridy lahko vpliva na druga zdravila ali na rezultate preiskav.
The Plegridy Initiation Pack contains 1x 63 micrograms pre-filled syringe (orange labelled syringe, 1st dose) and 1x 94 micrograms pre-filled syringe (blue labelled syringe, 2nd dose) in sealed plastic trays. 
Začetno pakiranje zdravila Plegridy vsebuje 1 x 63-mikrogramsko napolnjeno injekcijsko brizgo (brizga z oranžno nalepko, 1. odmerek) in 1 x 94-mikrogramsko napolnjeno injekcijsko brizgo (brizga z modro nalepko, 2. odmerek) na zatesnjenih plastičnih pladnjih.
Step 4: Choose and clean your injection site a. Choose an injection site in your thigh, abdomen, or the back of your upper arm (see highlighted areas in Figure D). 
a. Izberite mesto injiciranja na stegnu, trebuhu ali hrbtni strani nadlahti (glejte označena območja na sliki D).
Plegridy also significantly reduced the risk of relapse by 39% (p=0.0003), the risk of sustained disability progression confirmed at 12 weeks by 38% (p=0.0383) and at 24 weeks (post-hoc analysis) by 54% (p=0.0069), the number of new or newly enlarging T2 lesions by 67% (p<0.0001), the number of Gd-enhancing lesions by 86% (p<0.0001) and the number of new T1 hypointense lesions compared to placebo by 53% (p<0.0001). 
Plegridy je tudi značilno zmanjšalo tveganje za recidiv za 39 % (p = 0,0003), tveganje za trajno napredovanje bolezni, potrjeno pri 12. tednih za 38 % (p = 0,0383) in pri 24. tednih (analiza post-hoc) za
Plegridy 63 micrograms solution for injection in pre-filled syringe Plegridy 94 micrograms solution for injection in pre-filled syringe Plegridy 125 micrograms solution for injection in pre-filled syringe Plegridy 63 micrograms solution for injection in pre-filled pen Plegridy 94 micrograms solution for injection in pre-filled pen Plegridy 125 micrograms solution for injection in pre-filled pen 
Plegridy 63 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Plegridy 94 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Plegridy 125 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Plegridy 63 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku Plegridy 94 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku Plegridy 125 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku
Repeated dose toxicology studies were limited to 5 weeks as exposure was greatly diminished from 3 weeks onwards, due to the formation of anti-drug antibodies by rhesus monkeys to human interferon beta-1a. 
3 tednu močno zmanjšala, ker so se pri opicah Rhesus razvila protitelesa proti zdravilu na človeški interferon beta-1a.
Plegridy pre-filled syringe must not be used if the liquid is coloured, cloudy, or contains floating particles. 
Zdravilo Plegridy napolnjena injekcijska brizga se ne sme uporabiti, če je tekočina obarvana, motna ali če vsebuje plavajoče delce.
External heat sources such as hot water must not be used to warm Plegridy. 
Za ogrevanje zdravila Plegridy ni dovoljeno uporabljati zunanjih virov toplote, na primer vroče vode.
1 pre-filled syringe of 63 micrograms 1 pre-filled syringe of 94 micrograms 
1 napolnjena injekcijska brizga s 63 mikrogrami 1 napolnjena injekcijska brizga s 94 mikrogrami
Do not touch, clean, or manipulate the needle cover. 
Opozorilo: Varovala igle se ne dotikajte, ne čistite ga in ne posegajte vanj.
Sometimes you will need to remind other healthcare professionals that you are being treated with Plegridy. 
Včasih bo treba zdravstvene delavce opomniti, da se zdravite z zdravilom Plegridy, na primer, če vam želijo predpisati druga zdravila ali če pri vas opravljajo krvne preiskave.
Instructions for injecting Plegridy pre-filled syringe 
Navodila za injiciranje zdravila Plegridy napolnjena injekcijska brizga
Patients with relapsing-remitting MS have periods when the disease is not active (remission) in between flare-ups of symptoms (relapses). 
To prekine sporočila, ki potekajo med možgani in drugimi deli telesa, in povzroča simptome MS. Bolniki z recidivno-remitentno MS imajo med zagoni simptomov (recidivi) obdobja, ko bolezen ni aktivna (remisija).
Which dose 
Kolikšen odmerek
Box of two 125 microgram pre-filled pens (grey labelled pens) in a protective plastic tray. 
Škatla z dvema 125-mikrogramskima napolnjenima injekcijskima peresnikoma (peresnika s sivima nalepkama) na zatesnjenem plastičnem pladnju.
Precautions to be taken before handling or administering the medicinal product Once removed from the refrigerator, Plegridy should be allowed to warm to room temperature (up to 25°C) for about 30 minutes prior to injection. 
Zdravilo Plegridy naj se po odstranitvi iz hladilnika in pred injiciranjem ogreje na sobno temperaturo (do 25 °C) v približno 30 minutah.
Cases of TMA, manifested as thrombotic thrombocytopenic purpura (TTP) or haemolytic uraemic syndrome (HUS), including fatal cases, have been reported with interferon beta products. 
Trombotična mikroangiopatija (TMA) (učinki skupine) Pri uporabi zdravil z interferonom beta so poročali o primerih TMA, ki se kažejo kot trombotična trombocitopenična purpura (TTP) ali hemolitični uremični sindrom (HUS), vključno s smrtnimi primeri.
Hypothyroidism and hyperthyroidism have been observed with the use of interferon beta products. 
Pri uporabi zdravil z interferonom beta so opazili hipotiroidizem in hipertiroidizem.
Do not use more than one pen per 14-day period (every 2 weeks). 
Ne uporabite več kot enega peresnika v 14-dnevnem obdobju (vsaka 2 tedna).
Plegridy 125 mcg injection peginterferon beta-1a SC 
Plegridy 125 µg injekcija peginterferon beta-1a s.c.
Re-capping could cause the pen to lock. 
Pri ponovnem natikanju pokrova bi se namreč lahko zbodli.
Solution for injection Initiation Pack 
raztopina za injiciranje začetno pakiranje
Caution should be used when administering Plegridy to patients with severe renal impairment. 
Pri dajanju zdravila Plegridy bolnikom s hudo ledvično okvaro je potrebna previdnost.
The efficacy and safety of Plegridy was assessed from the placebo-controlled first year of a 2 year randomised, double-blind, clinical study in patients with relapsing remitting multiple sclerosis (the ADVANCE study). 
Učinkovitost in varnost zdravila Plegridy so ocenili v prvem letu 2-letne, s placebom kontrolirane,
- Throw away any syringe that is kept out of the fridge for more than 30 days. 
- Vsak peresnik, shranjen zunaj hladilnika več kot 30 dni, zavrzite.
Do not touch or blow this area again before giving the injection. 
Tega mesta se do injiciranja ne dotikajte več in nanj ne pihajte.
• Adhesive bandage 
• Napolnjeno injekcijsko brizgo zdravila
Plegridy 125 micrograms every 2 weeks 
Placebo Zdravilo Plegridy 125 mikrogramov vsaka 2 tedna
- The 125 micrograms grey syringes are provided in a pack containing either two or six pre-filled syringes. 
- Pakiranje s sivimi injekcijskimi brizgami s 125 mikrogrami vsebuje dve ali šest napolnjenih injekcijskih brizg.
Mean white blood cell counts remained within normal limits in patients treated with Plegridy. 
zdravljenih z zdravilom Plegridy, ostalo znotraj normalnih meja.
Do not reuse the Plegridy pre-filled syringe. 
Napolnjene injekcijske brizge zdravila Plegridy ne uporabite ponovno.
Step 6: Give the injection a. Hold the pen over your injection site. 
a. Injekcijski peresnik držite nad mestom za injiciranje.
Do not pull back on the plunger. 
Ne vlecite bata nazaj.
Urinary (renal) clearance is postulated to be a major excretory pathway for Plegridy. 
Domneva se, da je glavna pot izločanja zdravila Plegridy urinski (ledvični) očistek.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACK OUTER CARTON Pre-filled pen 125 mcg Multipack (with bluebox) 
SKUPNO PAKIRANJE ZUNANJA ŠKATLA Napolnjen injekcijski peresnik 125 µg skupno pakiranje (z »modrim okencem«)
b. Firmly press and hold down the pen on your injection site. 
b. Trdno pritisnite injekcijski peresnik na mesto injiciranja in ga držite pri miru.
No information is available on the potential effects of peginterferon beta-1a on male fertility. 
Informacij o možnih učinkih peginterferona beta-1a na plodnost pri moških ni na voljo.
Instructions for injecting Plegridy pre-filled syringe BEFORE YOU START How to inject Plegridy 
Navodila za injiciranje zdravila Plegridy napolnjena injekcijska brizga Kako injicirati zdravilo Plegridy
Quickly insert the needle straight into the skin fold until the needle is fully under the skin. 
Iglo vstavite naravnost v kožno gubo s hitrim gibom, tako da igla v celoti zdrsne v kožo (glejte sliko H).
Do not reuse your Plegridy pen. 
Injekcijskega peresnika zdravila Plegridy ne uporabite ponovno.
Dosage schedule 
Režim odmerjanja
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Pre-Filled Syringe Label Initiation Pack 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH Začetno pakiranje napolnjene injekcijske brizge, nalepka
• After the needle is in, let go of your skin. 
• Po vstavitvi igle kožno gubo izpustite.
(See Figure H). 
(navedeno v poglavju 6).
Annualised relapse rate Rate ratio 
Letni delež recidiva
Respiratory, thoracic and mediastinal disorders 
Bolezni dihal, prsnega koša in mediastinalnega prostora pljučna arterijska hipertenzija┼ neznana
• Plegridy pre-filled syringe is for injecting the medicine under the skin only (subcutaneous) 
• Napolnjena injekcijska brizga zdravila Plegridy je namenjena izključno injiciranju zdravila pod kožo
Very rare (<1/10,000) Not known (cannot be estimated from the available data) 
neznana (ni mogoče oceniti iz razpoložljivih podatkov) Organski sistem po MedDRA Neželeni učinek
Sodium acetate trihydrate Acetic acid, glacial Arginine hydrochloride Polysorbate 20 
FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi natrijev acetat trihidrat koncentrirana ocetna kislina argininijev klorid polisorbat 20 voda za injekcije
Do not use more than one pre-filled syringe per 14-day period (every 2 weeks). 
Ne uporabite več kot ene napolnjene injekcijske brizge v 14-dnevnem obdobju (vsaka 2 tedna).
• Close the pack and put pack back in the fridge after removing one pre-filled syringe. 
• Ko ste iz pakiranja vzeli eno napolnjeno injekcijsko brizgo, zaprite pakiranje in ga vrnite v hladilnik.
Musculoskeletal and connective tissue disorders 
Bolezni mišično-skeletnega sistema in vezivnega tkiva mialgija zelo pogosti artralgija
- If you have trouble handling the syringe, ask your doctor or nurse who may be able to help. 
- Če imate težave z uporabo brizge, prosite za pomoč zdravnika ali medicinsko sestro.
After your injection Step 9: Disposing of the used Plegridy pre-filled syringe 
9. korak: Zavrzite uporabljeno napolnjeno injekcijsko brizgo zdravila Plegridy.
The active substance in Plegridy is peginterferon beta-1a. 
Kaj je zdravilo Plegridy Učinkovina v zdravilu Plegridy je peginterferon beta-1a.
When you are ready to inject, carefully follow the instructions in section 7 “Instructions for injecting Plegridy pre-filled pen”, at the end of this leaflet. 
Preden začnete uporabljati zdravilo Plegridy, preberite navodila v poglavju 7 »Navodila za injiciranje zdravila Plegridy napolnjeni injekcijski peresnik« na koncu tega navodila.
This may cause the pen to accidently lock. 
To bi namreč lahko povzročilo nehoten zaklep injekcijskega peresnika.
Plegridy 63 mcg injection Plegridy 94 mcg injection peginterferon beta-1a SC 
Plegridy 63 µg injekcija Plegridy 94 µg injekcija peginterferon beta-1a s.c.
Race had no effect on the pharmacokinetics of peginterferon beta-1a in a population pharmacokinetic analysis. 
Populacijska farmakokinetična analiza ni pokazala učinkov rase na farmakokinetiko peginterferona beta-1a.
• Plegridy pre-filled syringe should be injected into the abdomen, thigh, or the back of the upper arm. (See Figure E). 
• Napolnjeno injekcijsko brizgo zdravila Plegridy je treba injicirati v trebuh, stegno ali zadnji del nadlahti.
When you are ready to inject, carefully follow the instructions in section 7 “Instructions for injecting Plegridy pre-filled syringe”, at the end of this leaflet. 
Preden začnete uporabljati zdravilo Plegridy, preberite navodila v poglavju 7 »Navodila za injiciranje zdravila Plegridy napolnjena injekcijska brizga« na koncu tega navodila.
Serum concentration of peginterferon beta-1a was dose-proportional in the range of 63 to 188 micrograms as observed in a single dose and a multiple dose study in healthy subjects. 
Koncentracija peginterferona beta-1a v serumu je bila sorazmerna z odmerkom in v razponu od 63 do
How to store Plegridy 
Shranjevanje zdravila Plegridy
Decreased peripheral blood counts in all cell lines, including rare pancytopenia and severe thrombocytopenia, have been reported in patients receiving interferon beta. 
Pri bolnikih, ki so prejemali interferon beta, so poročali o zmanjšanju perifernih krvnih vrednosti vseh celičnih vrst, vključno z redko pancitopenijo in hudo trombocitopenijo.
First injection: 63 micrograms, choose orange pen 
Prva injekcija: 63 mikrogramov, izberite oranžno brizgo dan 14 (94 mikrogramov)
Warnings and precautions Talk to your doctor if you have ever had: 
Opozorila in previdnostni ukrepi Posvetujte se z zdravnikom, če ste kadar koli imeli: - depresijo ali težave, ki vplivajo na vaše razpoloženje, - misli o tem, da bi naredili samomor,
Close the pack and put back in the fridge after removing one pen. 
Ko ste iz pakiranja vzeli en injekcijski peresnik, zaprite pakiranje in ga vrnite v hladilnik.
Step 10: Care for your injection site 
10. korak: Negujte mesto injiciranja.
Treatment with Plegridy should not be restarted (see section 
Zdravljenja z zdravilom Plegridy se ne sme ponovno uvesti (glejte poglavje 4.8).
Of a total of 1468 patients, 658 patients continued at least 4 years of treatment with Plegridy. 
Plegridy z neprekinjenim zdravljenjem do 4 leta, kot kažejo klinična merila in merila MRS za aktivnost bolezni MS. Od vsega skupaj 1.468 bolnikov je 658 bolnikov nadaljevalo zdravljenje z zdravilom Plegridy vsaj 4 leta.
1 pre-filled pen of 63 micrograms 1 pre-filled pen of 94 micrograms 
1 napolnjen injekcijski peresnik s 63 mikrogrami 1 napolnjen injekcijski peresnik s 94 mikrogrami
If you get some or all of these symptoms: - Increased bruising or bleeding - Extreme weakness - Headache, dizziness or light-headedness 
- pogostejše modrice ali krvavitve, - izjemna šibkost, - glavobol, omotica ali vrtoglavica,
Alopecia$ 
Bolezni kože in podkožja alopecija$
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Pre-Filled Pen Label Initiation pack 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH Začetno pakiranje napolnjenega injekcijskega peresnika, nalepka
Step 9: Dispose of used Plegridy pen 
9. korak: Zavrzite uporabljeni injekcijski peresnik zdravila Plegridy.
Less than 1% of Plegridy treated patients experienced a serious hypersensitivity event (e.g. angioedema, urticaria) and they recovered promptly after treatment with anti-histamines and/or corticosteroids. 
zdravljenih z zdravilom Plegridy, se je pojavil resen preobčutljivostni dogodek (npr. angioedem, urtikarija),
Pack sizes: - The Plegridy Initiation Pack contains one orange pre-filled syringe of 63 micrograms and one blue pre-filled syringe of 94 micrograms. 
- Začetno pakiranje zdravila Plegridy vsebuje eno oranžno napolnjeno injekcijsko brizgo s 63 mikrogrami in eno modro napolnjeno injekcijsko brizgo s 94 mikrogrami.
No gender effect on the pharmacokinetics of peginterferon beta-1a was found in a population pharmacokinetic analysis. 
Populacijska farmakokinetična analiza ni pokazala učinkov spola na farmakokinetiko peginterferona beta-1a.
Preparing for your injection Step 1: Remove your pen from the fridge. 
1. korak: Vzemite injekcijski peresnik iz hladilnika.
• If needed, apply a gauze pad or adhesive bandage or plaster to the injection site. 
• Po potrebi mesto injiciranja prekrijte z blazinico iz gaze ali obližem.
Do not use the Plegridy pre-filled syringe if the liquid is coloured, cloudy, or has floating particles in it. o You might see air bubbles in the Plegridy medicine. 
Ne uporabite napolnjene injekcijske brizge zdravila Plegridy, če je tekočina obarvana, motna ali so v njej prisotni delci.
What Plegridy is used for 
Za kaj uporabljamo zdravilo Plegridy
Injection Site 
Mesto injiciranja
In post marketing experience, serious hypersensitivity events including cases of anaphylaxis (frequency not known) have been reported following Plegridy administration. 
V obdobju trženja zdravila so po dajanju zdravila Plegridy poročali o resnih preobčutljivostnih dogodkih, vključno s primeri anafilaksije
Plegridy 125 micrograms solution for injection in pre-filled syringe peginterferon beta-1a 
Plegridy 125 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku peginterferon beta-1a
- If you have trouble handling the pen, ask your doctor or nurse who may be able to help. 
- Če imate težave z uporabo peresnika, prosite za pomoč zdravnika ali medicinsko sestro.
Initiation Pack. 
- Navodilo shranite.
Hypersensitivity Anaphylaxis1 
Bolezni imunskega sistema angioedem občasni preobčutljivost anafilaksija1
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Pre-Filled Syringe Label 125 mcg 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH Napolnjen injekcijski peresnik 125 µg, nalepka
Solution for injection 2 pre-filled pens. 
raztopina za injiciranje 2 napolnjena injekcijska peresnika.
Proportion of subjects relapsed HR 
Delež oseb z recidivom
No information is available on the effects of peginterferon beta-1a on male fertility in animals. 
Informacij o učinkih peginterferona beta-1a na plodnost pri samcih živali ni na voljo.
Solution for injection 2 pre-filled pens 
raztopina za injiciranje 2 napolnjena injekcijska peresnika
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Pre-Filled Syringe Double Lid Initiation Pack 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
Plegridy 125 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 125 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection. 
Plegridy 125 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 125 mikrogramov peginterferona beta-1a* v 0,5 ml raztopine za injiciranje.
Injection site reactions, including injection site necrosis, have been reported with the use of subcutaneous interferon beta. 
Pri uporabi subkutanega interferona beta so poročali o reakcijah na mestu injiciranja, vključno z nekrozo na mestu injiciranja.
Do not share your Plegridy pen. 
Injekcijskega peresnika zdravila Plegridy ne delite z drugimi.
c. Let your injection site dry on its own before injecting your dose. 
c. Pred injiciranjem odmerka počakajte, da se mesto za injiciranje samo posuši.
Day 28 and then every two weeks after that (125 micrograms) 
125 mikrogramov (za dan 28 in nato vsaka dva tedna).
Pre-Filled Pen 125 mcg Multipack (without bluebox) 
SKUPNO PAKIRANJE NOTRANJA ŠKATLA Napolnjen injekcijski peresnik 125 µg skupno pakiranje (brez »modrega okenca«)
Day 14 
2. odmerek 14. dan modra
In the ATTAIN extension study, long-term efficacy with Plegridy was maintained with continuous treatment up to 4 years as shown by clinical and MRI measures of MS disease activity. 
V podaljšani študiji ATTAIN so vzdrževali dolgoročno učinkovitost z zdravilom
Peginterferon beta-1a has not been tested for reproductive toxicity in pregnant animals. 
Vpliv na sposobnost razmnoževanja Peginterferon beta-1a ni bil testiran glede vpliva na sposobnost razmnoževanja pri brejih živalih.
HR: Hazard ratio 
RT: razmerje tveganja IZ: interval zaupanja
Step 7: Remove the Plegridy pen from your injection site a. After the clicking sound has stopped, lift the pen from your injection site. 
7. korak: Injekcijski peresnik zdravila Plegridy odstranite z mesta injiciranja.
Preparing for your injection Step 1: Remove your pre-filled syringe from the fridge 
1. korak: Vzemite napolnjeno injekcijsko brizgo iz hladilnika.
How to use Plegridy 
Kako deluje zdravilo Plegridy
- Irritation at an injection site, which can lead to skin and tissue damage (injection site necrosis). 
Težave se lahko med uporabo zdravila Plegridy poslabšajo: - resne težave z jetri ali ledvicami; - draženje na mestu injiciranja, ki lahko povzroči poškodovanje kože in tkiva (nekroza na mestu injiciranja).
Do not share your Plegridy pre-filled syringe. 
Napolnjene injekcijske brizge zdravila Plegridy ne delite z drugimi.
(uncommon - may affect up to 1 in 100 people) If you get any of these: - Difficulty breathing - Swelling around the face (lips, tongue or throat) - Skin rashes or redness 
(pojavijo se lahko pri največ 1 od 10 bolnikov) - siljenje na bruhanje (navzea) ali bruhanje, - izpadanje las (alopecija),
Each 63 microgram pre-filled syringe contains 63 micrograms of peginterferon beta-1a in 0.5 mL solution for injection. 
Ena 63-mikrogramska napolnjena injekcijska brizga vsebuje 63 mikrogramov peginterferona beta-1a v 0,5 ml raztopine za injiciranje.
• Plegridy pre-filled syringe is for subcutaneous injection (injection into skin). 
• Napolnjena injekcijska brizga zdravila Plegridy je namenjena za subkutano injiciranje
Each 125 microgram pre-filled syringe contains 125 micrograms of peginterferon beta-1a in 0.5 mL solution for injection. 
Ena 125-mikrogramska napolnjena injekcijska brizga vsebuje 125 mikrogramov peginterferona beta-1a v 0,5 ml raztopine za injiciranje.
Each 94 microgram pre-filled syringe contains 94 micrograms of peginterferon beta-1a in 0.5 mL solution for injection. 
Ena 94-mikrogramska napolnjena injekcijska brizga vsebuje 94 mikrogramov peginterferona beta-1a v 0,5 ml raztopine za injiciranje.
Solution for injection (injection). 
(injiciranju pod kožo).
- Headache - Muscle pain (myalgia) - Pain in your joints, arms, legs or neck (arthralgia) - Chills - Fever - Feeling weak and tired (asthenia) - Redness, itching or pain around the place you have injected 
pireksija, glavobol, mialgija, mrzlica, bolečina na mestu injiciranja, astenija, pruritus na mestu injiciranja in artralgija.
Plegridy 63 micrograms solution for injection in pre-filled syringe Plegridy 94 micrograms solution for injection in pre-filled syringe peginterferon beta-1a 
Plegridy 63 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Plegridy 94 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi peginterferon beta-1a